OLUKOTUN ADEOYE Y — SEC Form 4 filings
SEC reporting owner CIK 1242615. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-20.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-05-24 to 2026-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 4 filings — 15,809 shares, $927,682 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 6,083 shares @ $68.04 ($413,887) in ARROWHEAD PHARMACEUTICALS, INC., filed 2025-12-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Director | 6 | — | 6 legs · 15,809 sh · $927,682 | 2 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | Director | 4 | — | — | 4 |
Form 4 filings — OLUKOTUN ADEOYE Y
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 2,000 @ $86.96 | EDGAR |
| 2026-05-14 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 3,090 @ $66.70 · Sale (S): 6,083 @ $68.04 · Sale (S): 827 @ $68.48 | EDGAR |
| 2025-12-18 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/award (A): 7,819 @ $0 | EDGAR |
| 2025-05-15 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Other (J): 0.81 @ $1.91 | EDGAR |
| 2025-01-27 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 959 @ $21 | EDGAR |
| 2024-12-30 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 2,850 @ $20 | EDGAR |
| 2024-12-20 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/award (A): 16,733 @ $22.99 | EDGAR |
| 2024-05-24 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/award (A): 104,621 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1242615 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →